1. Academic Validation
  2. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand

Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand

  • Virology. 2019 May;531:233-239. doi: 10.1016/j.virol.2019.03.013.
Hiroyasu Ito 1 Ayumu Kanbe 2 Akira Hara 3 Tetsuya Ishikawa 4
Affiliations

Affiliations

  • 1 Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. Electronic address: hito@gifu-u.ac.jp.
  • 2 Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan.
  • 3 Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan.
  • 4 Department of Medical Technology, Nagoya University School of Health Sciences, 1-20 Daikominami-1-chome, Higashi-ku, Nagoya, Aichi 461-8673, Japan.
Abstract

A persistent hepatitis B virus (HBV) Infection is characterized by a lack of or a weak immune response to HBV. Efficient induction of the HBV-specific immune response leads to the clearance of HBV. Stimulator of interferon (IFN) genes (STING) is a cytoplasmic sensor of intracellular DNA from microbes and host cells. In the present study, we examined the efficacy of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) that is a ligand of the STING pathway as an HBV vaccine Adjuvant. Wild-type (WT) mice and HBV-transgenic (HBV-Tg) mice were immunized with hepatitis B surface antigen (HBsAg) and cGAMP. The vaccination with HBsAg and cGAMP significantly enhanced the humoral and cellular immune response to HBsAg in WT and HBV-Tg mice. Cytokine production related to Th1 and Th2 responses and the activation of antigen-presenting cells in lymphoid tissues were induced by cGAMP. Vaccination using cGAMP may overcome tolerance in patients with chronic HBV Infection.

Keywords

Hepatitis B virus; Immune response; STING; Vaccination.

Figures
Products